Multicenter clinical study of hyperprolinemia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047739

Enrollment

Unknown

Registered

2021-06-25

Start date

2021-06-30

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperprolinemia

Interventions

Case series:No

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. <=28 days after birth; 2. Parents read the instructions, agree and sign the written informed consent; 3. Clinical diagnosis of hyperprolinemia.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
Mutation site;	—

Countries

China

Contacts

Public ContactFeng Zhichun

Department of Pediatrics, The Seventh Medical Center, PLA General Hospital

zhjfengzc@126.com+86 13321154215

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026